Advertisement
Advertisement
Coronavirus pandemic
Get more with myNEWS
A personalised news feed of stories that matter to you
Learn more
The Pfizer Covid-19 vaccine vials are supposed to hold five doses, but pharmacists have found they have enough for a sixth or even a seventh dose. Photo: Bloomberg

Politico | Coronavirus: FDA says Pfizer vaccine vials hold extra doses, expanding supply

  • Using every drop from overfilled vials could boost available doses by up to 40 per cent
  • Some pharmacists had thrown away leftover vaccine due to confusion over US agency’s rules

This story is published in a content partnership with POLITICO. It was originally reported by Sarah Owermohle on politico.com on December 16, 2020.

Pharmacists have found a way to squeeze extra doses out of vials of Pfizer‘s vaccine, potentially expanding the nation’s scarce supply by up to 40 per cent.

The Food and Drug Administration said late on Wednesday that those extra doses could be used, clearing up confusion that had caused some pharmacists to throw away leftover vaccine for fear of violating the rules the agency set last week.

“Given the public health emergency, FDA is advising that it is acceptable to use every full dose obtainable,” an agency spokesperson told POLITICO, mirroring language that a federal health official sent to state vaccine providers on Wednesday morning.

03:58

Poor countries said to be left behind in Covid-19 vaccine race as rich nations get first doses

Poor countries said to be left behind in Covid-19 vaccine race as rich nations get first doses

The federal government has not publicly announced the guidance; Pfizer learned of the change this afternoon.

The Pfizer vials are supposed to hold five doses, but pharmacists have found they have enough for a sixth or even a seventh dose. Putting those into use could significantly increase the United States‘ scarce early supply of the shot, reducing the likelihood of a “vaccine cliff” this spring as demand outpaces supply.

Manufacturers typically overfill vaccine vials to safeguard against spills and other waste, said Erin Fox, a pharmacy expert at University of Utah who monitors drug shortages. “It’s pretty unusual to have a full extra dose or more though – but it does seem to be there!” she said in an email.

As more Covid-19 vaccines approach the finish line, producers face new hurdles

But many pharmacists, left confused without federal clarity, threw away hundreds of extra doses since vaccinations began on Monday. In Utah, Fox said, pharmacists are advised to stick to the FDA emergency use guidelines, which dictate that there are five doses.

Pharmacists nationwide swiftly noticed the extra supply, prompting outreach to Pfizer itself.

“The amount of vaccine remaining in the multidose vial after removal of five doses can vary, depending on the type of needles and syringes used,” Pfizer spokesperson Sharon Castillo told POLITICO.

“At this time, we cannot provide a recommendation on the use of the remaining amount of vaccine from each vial. Vaccinators need to consult their institution’s policies for the use of multidose vials.”

01:56

First Covid-19 vaccine administered as US death toll passes 300,000

First Covid-19 vaccine administered as US death toll passes 300,000

Both Pfizer and FDA said that leftover vaccine from multiple vials should not be mixed, because of the contamination risk.

Former Obama administration acting CMS chief Andy Slavitt tweeted about the potential vaccine wastage on Tuesday and insisted that Pfizer is now submitting paperwork to let pharmacists use the extra doses if they are available.

“I think this is more clever pharmacists than something missed by Pfizer,” he told POLITICO.

Operation Warp Speed head begs Trump to encourage supporters to get vaccine

Castillo said that Pfizer continue “to closely coordinate with the FDA on this matter.”

The possibility of more doses in the existing Pfizer supply comes amid pressure from the US government, after passing on options to buy more this fall, for the company to provide additional shots early next year.

HHS Secretary Alex Azar said on Wednesday that the administration is negotiating with Pfizer for more than the 100 million doses it originally promised, but Pfizer CEO Albert Bourla has said the company cannot provide those shots until this summer.

Rachel Roubein contributed.

Read Politico’s story.

Post